Stock 002432 ANDON HEALTH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Andon Health Co., Ltd.

Equities

002432

CNE100000Q84

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
40.09 CNY -2.55% Intraday chart for Andon Health Co., Ltd. -0.45% +6.42%
Apr. 28 Andon Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Andon Health Co., Ltd.'s Equity Buyback Plan announced on February 6, 2024. CI

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 4,034 2,225 2,199 3,995 23,126 23,314
Enterprise Value (EV) 1 3,598 2,005 1,665 3,164 22,163 11,872
P/E ratio -24.5 x 171 x 33.9 x 16.5 x 24.8 x 1.49 x
Yield - - - 0.65% 1.41% 4.89%
Capitalization / Revenue 6.75 x 3.95 x 3.11 x 1.99 x 9.65 x 0.89 x
EV / Revenue 6.02 x 3.56 x 2.36 x 1.58 x 9.25 x 0.45 x
EV / EBITDA -26.7 x -18.4 x -9.6 x 7 x 23.5 x 0.64 x
EV / FCF -177 x -3.89 x -106 x 11.4 x -5,198 x 1.03 x
FCF Yield -0.56% -25.7% -0.95% 8.76% -0.02% 97.3%
Price to Book 2.95 x 1.44 x 1.32 x 2.12 x 7.86 x 1.23 x
Nbr of stocks (in thousands) 432,806 432,806 432,806 432,806 466,729 456,157
Reference price 2 9.320 5.140 5.080 9.230 49.55 51.11
Announcement Date 4/26/18 4/29/19 6/28/20 4/27/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 597.9 563.9 706.3 2,008 2,397 26,315
EBITDA 1 -134.9 -109.1 -173.5 452.2 943.2 18,528
EBIT 1 -181.7 -132.7 -200.5 423.6 919.3 18,497
Operating Margin -30.39% -23.53% -28.39% 21.09% 38.35% 70.29%
Earnings before Tax (EBT) 1 -157.5 -4.93 18.38 239.8 999.6 18,258
Net income 1 -165.9 12.69 66.45 242.3 908.6 16,030
Net margin -27.74% 2.25% 9.41% 12.07% 37.91% 60.92%
EPS 2 -0.3800 0.0300 0.1500 0.5600 1.999 34.30
Free Cash Flow 1 -20.3 -516.1 -15.77 277.1 -4.264 11,552
FCF margin -3.4% -91.53% -2.23% 13.8% -0.18% 43.9%
FCF Conversion (EBITDA) - - - 61.29% - 62.35%
FCF Conversion (Net income) - - - 114.37% - 72.07%
Dividend per Share - - - 0.0600 0.7000 2.500
Announcement Date 4/26/18 4/29/19 6/28/20 4/27/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3
Net sales 1 - - - 1,726 1,495 787.3 462.3
EBITDA - - - - - - -
EBIT - - - - - - -
Operating Margin - - - - - - -
Earnings before Tax (EBT) - - - - - - -
Net income 14,312 15,244 806.7 - - - -
Net margin - - - - - - -
EPS 30.45 32.44 1.718 - - - -
Dividend per Share - - - - - - -
Announcement Date 4/29/22 8/29/22 10/28/22 4/28/23 4/28/23 8/29/23 10/31/23
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - - - -
Net Cash position 1 435 219 533 831 964 11,443
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -20.3 -516 -15.8 277 -4.26 11,552
ROE (net income / shareholders' equity) -11.4% -0.2% 1.73% 13.8% 40.1% 144%
ROA (Net income/ Total Assets) -5.1% -4.14% -6.51% 12% 18% 90.1%
Assets 1 3,253 -306.5 -1,020 2,013 5,052 17,791
Book Value Per Share 2 3.160 3.560 3.840 4.350 6.300 41.50
Cash Flow per Share 2 1.510 1.010 0.7700 2.110 1.960 11.60
Capex 1 56.5 180 60.7 53.8 70.4 212
Capex / Sales 9.45% 31.87% 8.6% 2.68% 2.94% 0.81%
Announcement Date 4/26/18 4/29/19 6/28/20 4/27/21 4/29/22 4/28/23
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.66B
BIOMÉRIEUX Stock bioMérieux
-0.60% 12.95B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.84B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
+1.82% 5.5B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.61B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+7.34% 4.61B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-47.96% 3.4B
VITROLIFE AB Stock Vitrolife AB
-14.59% 2.08B
MYRIAD GENETICS, INC. Stock Myriad Genetics, Inc.
+1.57% 1.79B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.72B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 002432 Stock
  4. Financials Andon Health Co., Ltd.